Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys
This study has been completed.
Study NCT00001984   Information provided by National Institutes of Health Clinical Center (CC)
First Received: January 26, 2000   Last Updated: June 18, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Graft Rejection
Kidney Disease
Additional conditions recognized in this trial
Kidney Diseases
More general conditions related to this trial
Urologic Diseases
Interventions listed in this trial
Campath-1H
Additional drug interventions recognized in this trial
Alemtuzumab
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services